Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · 6-K

Scinai Immunotherapeutics Ltd.

SEC Filing

Filed Sep 21, 2026Accepted Sep 21, 2026, 7:00 AM EDTCIK 1611747Accession 0001213900-26-101636
Share

Company context

Current securities

Historical securities (1)

Recent company filings

  1. 6-K filingSep 8, 2026
  2. EFFECT filingAug 28, 2026
  3. POS AM filingAug 27, 2026
  4. 6-K filingAug 26, 2026
  5. 6-K filingAug 19, 2026

As-filed source

Primary evidence